EMA Committee for Medicinal Products for Veterinary Use (CVMP) and EFSA Panel on Biological Hazards (BIOHAZ), David Murphy, Antonia Ricci, Zanda Auce, J. Gabriel Beechinor, Hanne Bergendahl, Rory Breathnach, Jiří Bureš, João Pedro Duarte Da Silva, Judita Hederová, Peter Hekman, Cornelia Ibrahim, Emil Kozhuharov, Gábor Kulcsár, Eva Lander Persson, Johann M. Lenhardsson, Petras Mačiulskis, Ioannis Malemis, Ljiljana Markus‐Cizelj, Alia Michaelidou‐Patsia, Martti Nevalainen, Paolo Pasquali, Jean‐Claude Rouby, Johan Schefferlie, Wilhelm Schlumbohm, Marc Schmit, Stephen Spiteri, Stanko Srčič, Lollita Taban, Toomas Tiirats, Bruno Urbain, Ellen‐Margrethe Vestergaard, Anna Wachnik‐Święcicka, Jason Weeks, Barbara Zemann, Ana Allende, Declan Bolton, Marianne Chemaly, Pablo Salvador Fernandez Escamez, Rosina Girones, Lieve Herman, Kostas Koutsoumanis, Roland Lindqvist, Birgit Nørrung, Lucy Robertson, Giuseppe Ru, Moez Sanaa, Marion Simmons, Panagiotis Skandamis, Emma Snary, Niko Speybroeck, Benno Ter Kuile, Helene Wahlström, Keith Baptiste, Boudewijn Catry, Pier Sandro Cocconcelli, Robert Davies, Christian Ducrot, Christian Friis, Gregers Jungersen, Simon More, Cristina Muñoz Madero, Pascal Sanders, Marian Bos, Zoltan Kunsagi, Jordi Torren Edo, Rosella Brozzi, Denise Candiani, Beatriz Guerra, Ernesto Liebana, Pietro Stella, John Threlfall, Helen Jukes
EFSA J. 2017 Jan; 15(1): e04666. Published online 2017 Jan 24. doi: 10.2903/j.efsa.2017.4666